Company Filing History:
1 out of 832,912 Years Active: 1981
Title: Seppo E Kolehmainen: Innovator in Nucleotide Measurement
Introduction
Seppo E Kolehmainen is a notable inventor based in Titusville, FL (US). He has made significant contributions to the field of biological measurement, particularly in the selective determination of nucleotides in viable cells. His innovative approach has the potential to enhance the accuracy of biological assays.
Latest Patents
Kolehmainen holds a patent for a method titled "Selective determination of nucleotides in viable somatic and microbial." This patent describes a technique for measuring the concentration of nucleotides and the number of viable cells in a biological sample. The method involves treating a sample of cells with surface-active agents to selectively release nucleotides without damaging the cell membrane or walls. The concentration of nucleotides is then measured using a bioluminescent assay technique, allowing for the determination of viable cells in the sample. He has 1 patent to his name.
Career Highlights
Throughout his career, Kolehmainen has focused on developing methods that improve the understanding of cellular viability and function. His work has implications for various fields, including microbiology and medical diagnostics.
Collaborations
Kolehmainen has collaborated with Veikko Tarkkanen, contributing to advancements in their shared field of research. Their partnership has fostered innovation and the development of new methodologies.
Conclusion
Seppo E Kolehmainen's contributions to the field of nucleotide measurement exemplify the impact of innovative thinking in biological research. His patented method represents a significant advancement in the accurate assessment of viable cells, showcasing the importance of inventors in scientific progress.